Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling

In conclusion, our study revealed that oridonin could remarkably reverse the epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling pathway, which suggested that oridonin may be a potential candidate for the treatment of laryngeal carcinoma in the future.PMID:38464825 | PMC:PMC10920846 | DOI:10.7150/ijms.92182

Source: International Journal of Medical Sciences - March 11, 2024 Category: Biomedical Science Authors: Bo Kou Yuhan Shi Zhaoyue Zhou Yanning Yun Qun Wu Jinsong Zhou Wei Liu Source Type: research